Kevin Brennan
Finanzdirektor/CFO bei XILIO THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Kevin Brennan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kevin Brennan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| BCLS ACQUISITION CORP. | Financial Conglomerates | Director of Finance/CFO Director/Board Member | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chief Operating Officer General Counsel | |
| Pasteur Merieux MSD Ltd. | President | ||
| The University of Edinburgh | College/University | Doctorate Degree | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Biotechnology | Chief Executive Officer | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TOLMAR Therapeutics, Inc.
 TOLMAR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TOLMAR Therapeutics, Inc. provides healthcare services. The company's products include Eligard, a prostate cancer treatment, Aczone, a dermatology product for the treatment of acne, and Atrigel, a drug delivery system. Its drug delivery systems deliver medicines such as proteins and antibiotics. The company also makes Orajel and Cepacol mouth sore medicines. It is headquartered in Fort Collins, CO. | Pharmaceuticals: Major | Chairman | |
OraVax, Inc.
 OraVax, Inc. BiotechnologyHealth Technology Part of Sanofi, OraVax, Inc. is a company that has a slick name that taps into the words 'oral' and 'vaccine' in a subtle way. The company is based in Cambridge, MA. The company is a possible oral health brand, medical licensing service, app, or chemicals company. OraVax was acquired by Acambis Plc, part of Sanofi from September 22, 2008 on May 11, 1999 for $17.79 million. | Biotechnology | Director/Board Member | |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
FluGen, Inc.
 FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Director/Board Member | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Georgetown University | College/University | Undergraduate Degree | |
| University of Virginia | College/University | Doctorate Degree | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal | |
Reify Corp.
 Reify Corp. Packaged SoftwareTechnology Services Reify Corp. develops and markets machine vision and video analysis software-based phenotypic screens. The private company is based in Cambridge, MA. The company was founded by Andrew A. F. Hack. | Packaged Software | Founder | |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Life Sciences, Inc.
 Life Sciences, Inc. Medical SpecialtiesHealth Technology Life Sciences, Inc. is a private company that is committed to saving lives and futures by providing superior products and services for scientific research. The company is based in St. Petersburg, FL. The company's offerings include AMV-RT, T7 RNA Polymerase, RNase H, NASBA, Lyophilized Products, and Services. The company was founded by Roderick N. Carter. | Medical Specialties | Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman | |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Biotechnology | Director/Board Member | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Imperative Care, Inc.
 Imperative Care, Inc. Medical SpecialtiesHealth Technology Imperative Care, Inc. is a healthcare technology company, which provides solutions to solve problems in stroke. It focuses on medical technology designed to expedite and improve the effectiveness of treatment, giving patients a chance for optimal recovery. The company is headquartered in Campbell, CA. | Medical Specialties | Director/Board Member | |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 6 |
| Schweden | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 12 |
| Finance | 5 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 122 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 46 |
| Director of Finance/CFO | 30 |
| Undergraduate Degree | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Topper | 52 |
| Gino Santini | 26 |
| David J. Clark | 21 |
| Andrew Hack | 20 |
| Paul Clancy | 14 |
| Allene Diaz | 14 |
| Robert Alexander | 13 |
| Louis Brenner | 12 |
| Richard D. Katz | 12 |
| Mark J. Fitzpatrick | 12 |
| René Russo | 11 |
| Daniel Curran | 10 |
| Edward Wholihan | 10 |
| Sara Bonstein | 9 |
| Yuan Xu | 9 |
- Börse
- Insiders
- Kevin Brennan
- Unternehmensverbindungen
